
Anaeropharma Science, Inc.
Aneropharma Science, Inc. is a privately held drug discovery company based in Tokyo, Japan. The firm is developing a tumor selective therapeutic agent based on its proprietary technology which involves non-pathogenic and anaerobic bacteria. The bacteria are engineered to produce certain enzymes that transform pro-drugs into cyto-toxic agents selectively at tumor tissues. Because of the anaerobic nature of those bacteria, they tend to localize at the anaerobic environment of tumor tissues. The cyto-toxic agents eventually produced at the tumor tissues are expected to kill those surrounding tumor cells.
| Company | Anaeropharma Science, Inc. |
|---|---|
| URL | http://www.anaeropharma.co.jp/ |
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
Mitsui Ventures Launching a New Approach to Seed Financing

